DSFCL
DCM Shriram Fine Chemicals Limited
DCM Shriram Fine Chemicals Limited (DSFCL) financial statements and selected valuation metrics through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
dsfcl.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
DCM Shriram Fine Chemicals makes organic and fine chemicals in India, including agro intermediates and a pharmaceutical intermediate line.
Company snapshot
60thBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
- ✓Debt-to-equity of 0.04x — the company is largely funded by its own money, not borrowed funds.
- ✗Net margin is negative — the company is spending more than it earns right now.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|
| Sales | 97 Cr | 93 Cr | 91 Cr |
| Operating expenses (approx.) | 97 Cr | 96 Cr | 86 Cr |
| EBITDA | 0.32 Cr | -3 Cr | 5 Cr |
| OPM % | 0.3% | -2.7% | 5.6% |
| Other income | 0.81 Cr | 0.74 Cr | 1 Cr |
| Interest | 0.24 Cr | 0.69 Cr | 0.44 Cr |
| Depreciation | 2 Cr | 2 Cr | 2 Cr |
| Profit before tax | -1 Cr | -5 Cr | 4 Cr |
| Tax % | -22.1% | 15.3% | 31.2% |
| Net profit | -1 Cr | -4 Cr | 3 Cr |
| EPS (₹) | ₹-0.17 | ₹-0.44 | ₹0.30 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 386 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 382 Cr | Sign in free for the trailing twelve months |
| EBITDA | 4 Cr | Sign in free for the trailing twelve months |
| OPM % | 0.9% | Sign in free for the trailing twelve months |
| Other income | 3 Cr | Sign in free for the trailing twelve months |
| Interest | 1 Cr | Sign in free for the trailing twelve months |
| Depreciation | 9 Cr | Sign in free for the trailing twelve months |
| Profit before tax | -3 Cr | Sign in free for the trailing twelve months |
| Tax % | -12.4% | Sign in free for the trailing twelve months |
| Net profit | -4 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹-0.41 | Sign in free for the trailing twelve months |
| Dividend payout % | — | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 17 Cr |
| Reserves | 194 Cr |
| Borrowings | 8 Cr |
| Other liabilities | 77 Cr |
| Total liabilities | 295 Cr |
| Fixed assets (net) | 98 Cr |
| CWIP | 0.23 Cr |
| Investments | 33 Cr |
| Inventories | 41 Cr |
| Trade receivables | 70 Cr |
| Cash & bank | 21 Cr |
| Other assets | 32 Cr |
| Total assets | 295 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 16 Cr |
| Cash from investing | 11 Cr |
| Cash from financing | -6 Cr |
| Net cash flow | 21 Cr |
| Free cash flow (OCF − Capex) | 14 Cr |
Ratios
| Metric | Mar 2026 |
|---|---|
| ROCE % | -0.8% |
| ROE % | -1.7% |
| Debtor days | 66 |
| Inventory days | 66 |
| Days payable | 80 |
| Cash conversion cycle | 52 |
| OCF / EBITDA % | n.m. |
| Debt / equity | 0.04 |
| Current ratio | 2.76 |
| Net debt / EBITDA | -3.67 |